Solvay Cilansetron Irritable Bowel Safety Trial Size Reflects FDA Concerns

Solvay's proposed 1,000-patient pivotal safety trial for the irritable bowel syndrome drug cilansetron reflects FDA's concern about the size of the safety database for IBS therapies.